Literature DB >> 6331304

Characterization of latent infections in mice inoculated with herpes simplex virus which is clinically resistant to acyclovir.

H J Field, E Lay.   

Abstract

Mice were inoculated into the ear pinna with herpes simplex virus (HSV) using a strain which is resistant to acyclovir (ACV) chemotherapy. The original inoculum was resistant to ACV because it contained a proportion of thymidine kinase-defective (TK-) virions. This had been obtained previously by passage of an HSV type 1 strain in mice undergoing suboptimal therapy. The cervical dorsal root ganglia were subsequently explanted from the infected mice and the presence of latent virus therein revealed by reactivation in vitro. These explant cultures yielded both TK+ and TK- viruses on reactivation. The establishment of latent infections was not affected by chemotherapy during the acute infection. One TK- ganglion isolate when studied in detail was found to be attenuated and thus resembled previously examined TK- strains which had been selected in vitro for ACV-resistance.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6331304     DOI: 10.1016/0166-3542(84)90024-x

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  11 in total

Review 1.  Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management.

Authors:  Jocelyne Piret; Guy Boivin
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

2.  Thymidine kinase-deficient herpes simplex virus type 2 genital infection in guinea pigs.

Authors:  L R Stanberry; S Kit; M G Myers
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

3.  Pathogenicity of herpes simplex virus mutants containing drug resistance mutations in the viral DNA polymerase gene.

Authors:  H J Field; D M Coen
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

4.  Comparative methods for detection of thymidine kinase-deficient herpes simplex virus type 1 strains.

Authors:  J Harmenberg; V A Sundqvist; H Gadler; B Levén; G Brännström; B Wahren
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

5.  In vitro and in vivo characterization of herpes simplex virus clinical isolates recovered from patients infected with human immunodeficiency virus.

Authors:  E L Hill; G A Hunter; M N Ellis
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

6.  An acyclovir-resistant strain of herpes simplex virus type 2 which is highly virulent for mice.

Authors:  S Sakuma; M Yamamoto; Y Kumano; R Mori
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

Review 7.  Persistent herpes simplex virus infection and mechanisms of virus drug resistance.

Authors:  H J Field
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-08       Impact factor: 3.267

8.  Molecular analysis of a neurovirulent herpes simplex virus type 2 strain with reduced thymidine kinase activity.

Authors:  S Tanaka; Y Toh; R Mori
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

9.  The pathogenesis of wild type and drug resistant mutant strains of bovine herpesvirus-1 (BHV-1) in the natural host.

Authors:  S E Gilliam; A M Thackray; G A Brown; H J Field
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

10.  High-frequency phenotypic reversion and pathogenicity of an acyclovir-resistant herpes simplex virus mutant.

Authors:  Anthony Griffiths; Donald M Coen
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.